Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
16.0%
% of CANC's 50 holdings also in PBE
28.6%
% of PBE's 28 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 4.1% | 3.0% | 3.0% |
|
AMGEN INC | 3.0% | 5.7% | 3.0% |
|
BLUEPRINT MEDICINES CORP. | 2.7% | 2.6% | 2.6% |
|
GILEAD SCIENCES INC | 1.9% | 6.7% | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.1% | 4.9% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
|
ELI LILLY & CO | 5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% |
|
REVOLUTION MEDICINES, INC. | 5.1% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
 |
ASTRAZENECA PLC | 4.5% |
|
NOVARTIS AG | 4.1% |
 |
GENMAB A/S SPONSORED ADR | 3.7% |
|
BRIDGEBIO PHARMA, INC. | 3.6% |
|
NUVALENT, INC. CLASS A | 3.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.1% |
CANC Underweight Relative to PBE
|
BIOGEN IDEC INC | -4.9% |
|
GILEAD SCIENCES INC | -4.8% |
|
UNITED THERAPEUTICS CORP | -4.5% |
|
NATERA INC | -4.4% |
|
INCYTE CORP | -4.2% |
|
REGENERON PHARMACEUTICALS | -3.8% |
|
HALOZYME THERAPEUTICS INC | -3.6% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |
|
TG THERAPEUTICS INC | -3.1% |